Emibetuzumab

REQUEST MORE INFO
Catalogue No: abx831310
Price: US$464.00
(Size: 100 µg)

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Emibetuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting MET/RCCP2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Emibetuzumab has been used in trials studying the treatment of Advanced Cancer, Renal Cell Carcinoma, Hepatocellular Cancer, Gastric Adenocarcinoma, and Non-Small Cell Lung Cancer, among others.

Target MET/RCCP2
Clonality Monoclonal
Reactivity Human
Expression Recombinant
Tested Applications ELISA, WB
Host Human
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Isotype IgG4 Kappa
Form Liquid
Purity > 95%
Purification Purified from cell culture supernatants by Protein A/G chromatography.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Buffer 0.01 M PBS. pH 7.4.
CAS Number 1365287-97-3
Concentration Batch-dependent, typically between 0.5-2.0 mg/ml.
Availability Shipped within 7-12 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on MET/RCCP2


Write a review

Tags:
(Click to show)